Methods: A total of thirty-eight adolescents (mean age 15.1 ± 1.4 years; male 28 (73.7%); body mass index [BMI] 23.1 ± 5.5 kg/m 2 ) with suspected OSA were assessed with the WP200 and standard PSG simultaneously between July 2014 and September 2015 at a tertiary university hospital. All WP200 data were assessed according to the automatic algorithm, and PSG data were scored according to the RRC and RRA. We examined the correlation, agreement, and concordance in the apnea-hypopnea index (AHI) and minimum arterial oxygen saturation (mSaO2) between the WP200 and PSG-RRC or PSG-RRA. 
INTRODUCTION
Obstructive sleep apnea (OSA) is a chronic sleep disorder characterized by recurrent episodes of partial or complete collapse of the upper airway during sleep. 1 It can cause various symptoms and signs such as habitual snoring, restless sleep, sleepiness, behavioral problems and adaptive functioning difficulties such as attention deficit and reduced adaptive skills. [1] [2] [3] Undetected or untreated childhood OSA may lead to serious complications including metabolic and cardiovascular consequences. 4 Therefore, prompt and accurate diagnosis is required in patients with suspected OSA.
Traditionally, overnight full polysomnography (PSG; level 1) has been performed as a gold standard for diagnosing OSA. 1, 5 However, PSG has some drawbacks such as long waiting time, unfamiliar laboratory environment, and high cost. 6, 7 Consequently, out-of-center sleep testing using diverse home or portable monitoring devices has been developed to overcome these problems. 7 Among varied home or portable monitoring devices, Watch-PAT 200 (WP200; Itamar Medical Ltd., Caesarea, Israel) has a unique feature without conventional assessments such as airflow and respiratory effort. 8 In particular, this device measures respiratory events (e.g., apnea, hypopnea) using a distinct mechanism. Terminating respiratory disturbances induces decreased oxygen level, increased heart rate, and digital arterial vasoconstriction.
Vasoconstriction of fingertip causes reduced peripheral arterial tonometry (PAT) signal. 9 The Watch-PAT (WP) analyzes these parameter changes and reports the apnea-hypopnea index (AHI) based on the PAT signal.
Numerous validation studies for diagnosing OSA in adults using the WP200 have been performed, and these studies have shown that the device has high concordance in AHI severity, high correlation, and good agreement of AHI with attended, in-laboratory PSG (level 1). 10-14 6 However, there have been few validation studies of a wrist-worn device such as WP200 for the diagnosis of OSA in adolescents. We hypothesized that the device would be a useful alternative diagnostic method for OSA in adolescents. Therefore, the purpose of the study was to investigate the accuracy of the WP200 for identifying OSA in adolescents against standard PSG based on the respiratory rules for children (RRC) and adults (RRA).
METHODS

Subjects
This prospective study protocol was approved by the Institutional Review Board at the Ajou University Hospital (AJIRB-DEV-DE2-13-324). We enrolled adolescents aged 13 to 17 years with suspicious symptoms and/or signs of OSA (e.g., habitual snoring, daytime sleepiness, witnessed apnea, etc.) between July 2014 and September 2015 at a tertiary university hospital.
The exclusion criteria were as follows: (1) medical histories that could have interfered with test reliability (e.g., autonomic nervous system dysfunction, peripheral neuropathy or vasculopathy, cardiac or lung disease, etc.) or medications that could have affected peripheral arterial tone (e.g., alpha-adrenergic receptor-blocking agents, etc.); and (2) finger problems associated with unsuitable PAT probe application.
PSG and WP200
All adolescents underwent standard full PSG (Embla ® N7000; Natus Medical Inc., San Carlos, CA, USA) and the WP200 simultaneously in hospital-based sleep laboratories. 15 ; a physician finally confirmed the data. Pediatric and adult respiratory events including apnea and hypopnea were scored according to the "recommended" rule. Apnea in children (adults) was defined as the cessation of the respiratory airflow for the duration of at least two breaths (10 seconds). Obstructive apnea was defined as the cessation of airflow with continued respiratory effort (chest and abdominal movement) for the same duration. Hypopnea in children (adults) was defined as a decrease in respiratory airflow of ≥30% for the duration of at least two breaths (10 seconds), associated with oxygen desaturation of ≥3% or an arousal.
All PSG data were manually scored twice based on both rules. Pediatric rules were used and then adult rules were applied.
The WP200 measurements consisted of PAT signal, oxygen saturation, heart rate, wrist activity (actigraphy), snoring, and body position; the WP200 calculate these data using an automatic computerized algorithm.
After we completed interpreting the PSG and WP200 findings, we diagnosed OSA according to the International Classification of Sleep Disorders-Third Edition (ICSD-3) 1 . The diagnostic criteria for pediatric OSA were respiratory events ≥1 per hour of sleep with signs and/or symptoms suggestive of OSA (e.g., snoring, witnessed apnea, sleepiness, behavioral problems, etc.). The diagnostic criteria for adult OSA were (1) respiratory events ≥5 per hour of sleep with signs and/or symptoms suggestive of OSA (e.g., snoring, witnessed apnea, sleepiness, co- 
Statistical Analysis
All data in the study are presented as frequencies (percent) for categorical variables and as means ± standard deviations for continuous variables. To assess the diagnostic performance of the WP200 measurements, we used typical clinical criteria of 5, 10, and 15 events per hour for pediatric OSA and 5, 15, and 30 events per hour for adult OSA to calculate the diagnostic sensitivity, specificity, accuracy, positive and negative likelihood ratio (LR; LR+, LR-) values with 95% confidence interval. The Spearman's correlation coefficient and Bland-Altman plots were applied to evaluate the correlation and agreement of AHI and minimum arterial oxygen saturation (mSaO2) between PSG and WP200. Kendall's tau-b was applied to investigate the concordance of AHI between PSG and WP200. We performed all statistical analyses using R (version 3.3.2; The R Foundation for Statistical Computing, Vienna, Austria). All P values of less than 0.05 were considered to indicate statistical significance.
RESULTS
Subjects
We enrolled forty adolescents in this study, but thirty-nine subjects underwent the WP testing because one did not want to be tested. In addition, data from one adolescent were not available due to a test failure. Thus we ultimately enrolled a total of thirty-eight adolescents of mean age 15.4, P = .471). We also observed no significant differences in average mSaO2 between the WP200 and PSG (91.2 ± 5.4 vs. 91.4 ± 5.2, P = .31). There was a high correlation (r = 0.945, P < .001) and good agreement in mean AHI between the WP200 and PSG according to the RRC and RRA. In addition, a high correlation (r = 0.921, P < .001) and good agreement was found in average mSaO2 between the two OSA evaluation techniques (Figure 3 ). Table 2 summarizes the sensitivity, specificity, accuracy, LR+ and LR-of the WP200 with PSG according to the RRC and RRA. When AHI-RRC was used as the gold standard for diagnosis of adolescent OSA, the sensitivity, specificity, accuracy, and LR+ and LR-of different cut-off points of the AHI by the WP200 were as follows: at a cut-off point of ≥ 1, AHI by WP200 had sensitivity of 100%, specificity of 73%, and accuracy of 90% (LR+ 3.75, LR-0.00); at a cut-off of ≥ 5, sensitivity of 100%, specificity of 96%, and accuracy of 97% (LR+ 26.00, LR-0.00); and at a cut-off of ≥ 10, sensitivity of 75%, specificity of 93%, and accuracy of 89% (LR+ 11.25, LR-0.27). When we used AHI-RRA as the gold standard for diagnosis of adolescent OSA, the sensitivity, specificity, accuracy, and LR+ and LR-of different AHI cut-off points by the WP200 were as follows: at a cut-off of ≥ 5, AHI by WP200 had sensitivity of 100%, specificity of 96%, and accuracy of 97% (LR+ 26.00, LR-0.00); at a cut-off of ≥ 15, sensitivity of 80%, specificity of 100%, and accuracy of 97% (LR+ NA, LR-0.20); and at a cut-off of ≥ 30, sensitivity of 100%, specificity of 100%, and accuracy of 100% (LR+ NA, LR-0.00). Tables 3 and 4 show the concordance of AHI severity measured by the WP200 and PSG according to the RRC and RRA. We found significant high concordance in AHI severity between the WP200 and PSG according to the RRC (Kendall's tau-b = 0.848, P < .001) and RRA (Kendall's tau-b = 0.944, P < .001).
Diagnostic Performance of the WP200 with PSG
Concordance of AHI Severity
DISCUSSION
The present study undertook to validate the WP200 for diagnosing OSA in adolescents against attended overnight PSG. In addition, we tested to find out optimal respiratory scoring rules for children and adults in the diagnosis of adolescent OSA using the WP200 because an individual sleep specialist can adopt RRC or RRA to scoring respiratory events in adolescents (13) (14) (15) (16) (17) years) at his or her discretion. The results of the study showed that the WP200 not only had 11 significant concordances of AHI severity but also high correlations and good agreements in AHI and mSaO2 compared with in-laboratory PSG based on both respiratory rules. To the best of our knowledge, this is the first study to determine the reliability and clinical efficacy of the WP200 to diagnose OSA compared with PSG in adolescents according to the RRC and RRA.
Since the WP wrist-worn device using peripheral arterial tone measurements was developed in the late 1990s, there has been much clinical research to assess the accuracy and feasibility of the WP for identifying OSA. 9-14 Yalamanchali et al. 16 performed a review and meta-analysis of 14 clinical papers to estimate the correlation in respiratory parameters such as AHI between full PSG and the WP. They detected a relatively high degree of correlation in respiratory parameters between PSG and WP and concluded that the latter device provides valuable data for adequate diagnosis of OSA in adults. To identify the effects of older age and aging on the diagnostic precision of the Watch-PAT, Onder et al. 17 analyzed sleep and respiratory variables including AHI between younger (age ranges 20-35 years, n = 27) and older (age ranges 50-65 years, n = 29) adults. They found that there were high correlation and good agreement in AHI in each group between standard PSG and the WP and demonstrated that older age did not exert negative effects on the diagnostic accuracy of the WP.
Although the WP has some benefits including easy-to-use, automatic analysis of data, few adverse effects, low discomfort, and lower cost against in-laboratory PSG, it has a few clinical restrictions for use. For example, WP is not indicated for a number of conditions such as use of several medications (e.g., alpha blockers, short-acting nitrates, etc.), permanent pacemaker, sustained non-sinus cardiac arrhythmias, and age below 17 years. Considering the operating principle of a wrist-worn device using peripheral arterial tone measurements, most clinical limitations for application except age restrictions are easy to understand. In briefly, the operating mechanism of the WP related to identifying sleep-disordered breathing such as apnea and hypopnea is follows: (1) abruptly elevated sympathetic activation by the termination of respiratory events causes digital arterial vasoconstriction; (2) peripheral arterial vasoconstriction by mediated alpha-receptors leads to decreased PAT signal amplitude; and (3) attenuated PAT signal amplitude, reduced oxygen saturation, elevated pulse rate, and actigraphy are used to conduct comprehensive analysis by the automatic computerized algorithm for sleep reports including AHI. 9 However, it is thought that age limitations for use may be associated with the absence or deficiency of validation or feasibility studies in childhood and adolescents. The results of this study support the evidence that the WP200 may be useful for detecting respiratory disturbances such as sleep apnea and hypopnea and helpful for diagnosing OSA appropriately in adolescents.
Childhood OSA has several distinct differences from adulthood OSA such as clinical manifestations (e.g., adenotonsillar hypertrophy, uncommon daytime sleepiness, etc.) and PSG findings (e.g., respiratory events mainly occurred during rapid eye movement sleep, wellpreserved slow wave sleep, etc.). 18 On the contrary, adult OSA has some clinical features (e.g., obesity, small adenoid and tonsils, common daytime sleepiness, etc.) and PSG findings (e.g., respiratory events regardless of sleep stages in most moderate to severe cases, disturbed slowwave sleep, etc.) compared with children with OSA. 18 Adolescence can be defined as the transitional period between childhood and adulthood in the human growth process. Similarly, it is presumed that adolescent OSA exhibits clinical and PSG characteristics of both childhood and adulthood OSA. However, there is still a lack of information on adolescent OSA regardless of fields such as clinical features, diagnoses, or treatment. To evaluate the anatomical or structural risk factors for OSA in adolescents, Schwab et al. 19 compared three groups of adolescents with magnetic resonance imaging: (1) obese teens with OSA (n = 49); (2) obese control teens (n = 38); and 3) lean control teens (n = 50). The authors reported a number of 13 main outcomes as follows: (1) obese adolescents with OSA had enlarged adenoids and tonsils compared with other groups; (2) obese adolescents with OSA had narrower nasopharyngeal airways than other groups; and (3) there were no differences in the volume of other upper airway soft tissue anatomies between obese OSA adolescents and the obese control group. 19 To elucidate the differences in adolescents between RRC and RRA, Tapia et al. 20 and RRA (hypopnea rule B) whereas a significant discordance in classification was observed comparing RRC and RRA (hypopnea rule A). They found that either RRC or RRA (hypopnea rule B) can be applied for adolescents with suspected OSA. 21 This study has several limitations. First, there were relative small study participants. In the study, WP200 had a relatively high sensitivity and specificity at different cut-off points of the AHI regardless of scoring criteria. However, the sensitivity at a cut-off of ≥ 10 of the AHI-RRC was 75% (6/8). Only two of eight adolescents who were diagnosed with OSA (AHI ≥ 10)
by the PSG had less than 10 of the AHI by the WP. Further study needs to be carried out in a large number of subjects. Second, the WP does not provide sleep apnea results that distinguish it as central, obstructive or mixed type. In this study, no adolescents were diagnosed with central sleep apnea syndrome. Third, there is a possibility of failure during the WP testing. The failure rate of WP was 2.6% (1/39) in the study. One adolescent complained of finger pain 14 during the testing, and the examination could not proceed any further. We could find no cause in the other adolescent. Forth, overnight PSG did not include monitoring of CO2 in this study.
Currently, CO2 monitoring is recommended for the detection of pediatric obstructive hypoventilation. However, WP cannot monitor CO2 levels natively. Therefore, CO2 levels were not measured in the study and our results of the validation of WP did not contain any data related with pediatric obstructive hypoventilation. These inherent limitations should be considered before using the WP. Fifth, WP was not tested in the home environment where it is intended to be used. Future clinical researches are required considering these limitations.
CONCLUSIONS
In adolescents, the WP200 not only has significant concordances in AHI severity but also high correlations and good agreements in AHI and mSaO2 compared with attended in-laboratory PSG according to the RRC and RRA. The WP may be a clinically accurate diagnostic method for OSA in adolescents whether we used the respiratory scoring rules for children or adults.
Additional WP200 feasibility studies are needed with more adolescents. Table 1 -Characteristics of all adolescent subjects (n = 38). Sleep efficiency, % 85.1 ± 13.8
TABLES
Variable
Values are presented as mean ± standard deviation for continuous variables. BMI = body mass index, AHI = apnea-hypopnea index, RRC = respiratory rules for children, RRA = respiratory rules for adults, mSaO2 = minimum arterial oxygen saturation.
